QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, February 23, 2005, 25(8):1992-2001; doi:10.1523/JNEUROSCI.4985-04.2005

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (21) Citing Articles via Google Scholar Google Scholar Articles by Akk, G. Articles by Steinbach, J. H. Search for Related Content PubMed PubMed Citation Articles by Akk, G. Articles by Steinbach, J. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CARBACHOL CHLORIDE CHOLINE BITARTRATE CHOLINE CHLORIDE

 Previous Article  |  Next Article 

Cellular/Molecular
Galantamine Activates Muscle-Type Nicotinic Acetylcholine Receptors without Binding to the Acetylcholine-Binding Site

Gustav Akk and Joe Henry Steinbach

Department of Anesthesiology, Washington University, St. Louis, Missouri 63110

Galantamine (Reminyl; Janssen Pharmaceutica, Titusville, NJ) belongs to a class of acetylcholinesterase inhibitors approved for symptomatic treatment of Alzheimer's disease. The drug presumably acts by raising and prolonging the profile of acetylcholine (ACh) via an inhibitory effect on the esterase. However, there is also evidence demonstrating that galantamine can activate the nicotinic ACh receptor or modulate its activation by ACh.

In this study, we have examined the ability of galantamine to directly activate the muscle-type nicotinic ACh receptor or to modulate receptor activation by selected nicotinic agonists.

Studies of direct activation by galantamine demonstrated that this ligand is a low-efficacy agonist of the muscle-type ACh receptor. Point mutations in the M2-M3 linker (S269I) and the M2 transmembrane domain (T264P) had similar effects on receptor activation by galantamine and nicotinic agonists, suggesting that the general features of receptor activation by galantamine are similar to that in the presence of ACh.

Experiments performed in the simultaneous presence of galantamine and various nicotinic ligands showed that channel activation by the nicotinic ligands studied (ACh, carbachol, and choline) was not affected by the presence of galantamine at concentrations up to 100 µM. In addition, galantamine did not reduce the initial rate of binding for ¹²⁵I--bungarotoxin. These results demonstrate that galantamine does not interfere with the occupation of the nicotinic agonist binding site by ACh, carbachol, or choline. We conclude that galantamine activates the muscle-type ACh receptor by interacting with a binding site that is distinct from the site for nicotinic agonists.

Key words: acetylcholinesterase; channel; gating; binding; inhibition; block

---

Received Dec 7, 2004; revised January 12, 2005; accepted January 13, 2005.

This article has been cited by other articles:

				S. Seo, J. T. Henry, A. H. Lewis, N. Wang, and M. M. Levandoski The Positive Allosteric Modulator Morantel Binds at Noncanonical Subunit Interfaces of Neuronal Nicotinic Acetylcholine Receptors J. Neurosci., July 8, 2009; 29(27): 8734 - 8742. [Abstract] [Full Text] [PDF]

				E. X. Albuquerque, E. F. R. Pereira, M. Alkondon, and S. W. Rogers Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function Physiol Rev, January 1, 2009; 89(1): 73 - 120. [Abstract] [Full Text] [PDF]

				J. Militante, B.-W. Ma, G. Akk, and J. H. Steinbach Activation and Block of the Adult Muscle-Type Nicotinic Receptor by Physostigmine: Single-Channel Studies Mol. Pharmacol., September 1, 2008; 74(3): 764 - 776. [Abstract] [Full Text] [PDF]

				S. Nirthanan, G. Garcia III, D. C. Chiara, S. S. Husain, and J. B. Cohen Identification of Binding Sites in the Nicotinic Acetylcholine Receptor for TDBzl-etomidate, a Photoreactive Positive Allosteric Effector J. Biol. Chem., August 8, 2008; 283(32): 22051 - 22062. [Abstract] [Full Text] [PDF]

				T.-Y. Wu, C. M. Smith, S. M. Sine, and M. M. Levandoski Morantel Allosterically Enhances Channel Gating of Neuronal Nicotinic Acetylcholine {alpha}3{beta}2 Receptors Mol. Pharmacol., August 1, 2008; 74(2): 466 - 475. [Abstract] [Full Text] [PDF]

				G. Akk, L. S Milescu, and M. Heckmann Activation of heteroliganded mouse muscle nicotinic receptors J. Physiol., April 15, 2005; 564(2): 359 - 376. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help